News Archive

The registry, which has enrolled 1,002 patients with idiopathic pulmonary fibrosis, shares critical knowledge and insights to help combat lung disease.

Data provided to the FDA by the research network has helped to provide a fuller picture for prescribing these medications to pediatric populations.

A pragmatic comparative effectiveness study comparing Micra leadless pacemakers to conventional transvenous pacemakers found that for patients who received the novel leadless pacemakers, complicati

A cardiologist and internationally recognized clinical research expert will become the Institute’s new leader.

In response to the COVID-19 pandemic, the POP02 study has expanded its protocol to include antiviral drugs that could be used to treat pediatric patients with COVID-19.

A paper authored by the DCRI’s Adrian Hernandez, MD, MHS, and colleagues calls for major changes in the research ecosystem to enable pragmatic trials, especially those comparing different treatment

The collaboration will initially focus on projects related to heart failure, coronary and vascular disease, and atrial fibrillation.

The HERO registry, which can be joined at HeroesResearch.org, will enroll thousands of healthcare workers to answer crucial questions about the impact of novel coronavirus on their lives.

The study is the first cardiovascular outcomes trial to compare two different types of cancer treatment.

A DCRI-led study found that using oral anticoagulants, predominantly warfarin, led to increased risk of bleeding and intracranial hemorrhage for patients with atrial fibrillation and end-stage renal disease.